Abbott Laboratories

ABT

$108.15

+24.57% (1 year change)

Avg closing price

Price range

Market Cap

$191 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$7.33 Billion

Total revenue in the last quarter.

Net Income

$534 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$1.9

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$1.44 (1.34%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

56.59x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$642 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

107,000

The number of full time employees.

Revenue & Earnings

Balance Sheet

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

News

Lateral Flow Assays Market worth USD 10.2 billion by 2025 - Leading Companies are Abbott Laboratories, F. Hoffman-La Roche Ltd, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, and bioMérieux SA

Lateral Flow Assays Market worth USD 10.2 billion by 2025 - Leading Companies are Abbott Laboratories, F. Hoffman-La Roche Ltd, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, and bioMérieux SA

According to the new market research report "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lip...

OpenPR OpenPR, 9 days ago
Medical Disposables Market with Covid-19 Effect Analysis | likewise Industry is Booming Globally with Key Players Abbott Laboratories, Johnson & Johnson, Ansell Limited, Becton and Dickinson Company (BD)

Medical Disposables Market with Covid-19 Effect Analysis | likewise Industry is Booming Globally with Key Players Abbott Laboratories, Johnson & Johnson, Ansell Limited, Becton and Dickinson Company (BD)

This is often the latest report, covering the present COVID-19 impact on the Medical Disposables Market. The Medical Disposables market research report classifies the market into different segments...

OpenPR OpenPR, 11 days ago
Insights on the Influenza Diagnostics Global Market to 2026 - Featuring Abbott Laboratories, Hologic and Becton Among Others - ResearchAndMarkets.com

Insights on the Influenza Diagnostics Global Market to 2026 - Featuring Abbott Laboratories, Hologic and Becton Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Influenza Diagnostics Market by Test Type, by End-user, Geography - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. Influenza is a highly...

Business Wire Business Wire, 18 days ago